Last reviewed · How we verify
Acetyl-L-Carnitine — Competitive Intelligence Brief
marketed
Amino acid derivative / Metabolic agent
Carnitine palmitoyltransferase (CPT) system
Neurology, Geriatrics, Metabolic disorders
Small molecule
Live · refreshed every 30 min
Target snapshot
Acetyl-L-Carnitine (Acetyl-L-Carnitine) — Dong-A ST Co., Ltd.. Acetyl-L-Carnitine facilitates the transport of long-chain fatty acids into mitochondria for β-oxidation, enhancing cellular energy production.
Comparator set (1 drugs)
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Acetyl-L-Carnitine TARGET | Acetyl-L-Carnitine | Dong-A ST Co., Ltd. | marketed | Amino acid derivative / Metabolic agent | Carnitine palmitoyltransferase (CPT) system | |
| L-acetyl carnitine | L-acetyl carnitine | University of Campania Luigi Vanvitelli | marketed | Amino acid derivative / Metabolic agent | Carnitine palmitoyltransferase (CPT) system |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape (Amino acid derivative / Metabolic agent class)
- Dong-A ST Co., Ltd. · 1 drug in this class
- University of Campania Luigi Vanvitelli · 1 drug in this class
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Acetyl-L-Carnitine CI watch — RSS
- Acetyl-L-Carnitine CI watch — Atom
- Acetyl-L-Carnitine CI watch — JSON
- Acetyl-L-Carnitine alone — RSS
- Whole Amino acid derivative / Metabolic agent class — RSS
Cite this brief
Drug Landscape (2026). Acetyl-L-Carnitine — Competitive Intelligence Brief. https://druglandscape.com/ci/acetyl-l-carnitine. Accessed 2026-05-14.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab